- 22 October 2021
Dr Anish Kotecha summarises a study into the use of the glucagon-like peptide-1 receptor agonist semaglutide, alongside a lifestyle intervention, to reduce weight.
The content of this website is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. Any distribution or duplication of the information contained herein is strictly prohibited.
© Oxbridge Solutions Ltd, 2021
GPnotebook Pro is currently available to UK healthcare professionals only
Thanks for your feedback. Please note that by including your email address, you are giving permission for us to contact you by email to help resolve any issues.
To get started, register for a GPnotebook Pro account, and then use your credentials to log in to GPnotebook TV
GPnotebook Pro is currently available to UK healthcare professionals only
You need to register for GPnotebook Pro in order to track your activity on GPnotebook TV
You’re now logged in, and the time you spend watching GPnotebook TV episodes will be tracked in your GPnotebook Pro CPD dashboard.
When the time is right, you can visit the dashboard to add reflective notes and claim CPD credits
Would you like to receive email updates about new videos? (You can unsubscribe at any time)